The Free and Hanseatic City of Hamburg will fund the integration and future growth of the new IME ScreeningPort with three million euro. Dr. Dorothee Stapelfeld, Hamburg Minister of Science, emphasises: “It has been an important target in the Senate’s strategy to integrate the European Screening Port in the Fraunhofer Gesellschaft to develop specific pre-clinical drug development in Hamburg. By networking with scientists at the DESY and the University Medical Centre, and Evotec as industrial partner, a first-class R & D location has thus been created.”
At the new site in Hamburg, 30 employees will add their scientific skills and expertise to the 600 personnel currently working on IME research activities, creating a new organisation called the IME-ScreeningPort (IME-SP). The new organization will act as a platform between basic research and industrial development and exploit synergies with other IME technology platforms along the drug discovery and development value chain. The Fraunhofer Institute for Molecular Biology and Applied Ecology IME is located in Aachen and operates branches in Gießen, Frankfurt, Münster, Schmallenberg and international centres in the USA and Chile.